| Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women (NCT05367973) | Daré Bioscience, Inc. | 2022-04-11 |
| Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms (NCT05637671) | Cairo University | 2022-02-10 |
| A Study of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause (NCT05033886) | Astellas Pharma Global Development, Inc. | 2021-11-08 |
| A Survey About Hot Flashes in Women Going Through the Menopause (NCT05083884) | Astellas Pharma Europe Ltd. | 2021-11-04 |
| FP-101 Versus Placebo in the Treatment of Menopausal Vasomotor Symptoms (NCT05312567) | Fervent Pharmaceuticals | 2021-03-24 |
| A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women (NCT05418426) | Daré Bioscience, Inc. | 2020-08-18 |
| Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I) (NCT04209543) | Estetra | 2019-12-30 |
| Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II) (NCT04090957) | Estetra | 2019-09-27 |
| The Effect of Health Education and Progressive Muscle Relaxation Exercise on Vasomotor Symptoms and Sleep Problems With Perimenopausal Women (NCT04808232) | Sidika Pelit Aksu | 2019-02-17 |
| Stellate Ganglion Blockade in Post-Menopausal Women (NCT02907983) | Northwestern University | 2018-07-10 |
| Determination of the Effects of Autogenic Relaxation Exercise and Cold Pillow Application on Vasomotor Symptom Control and Quality of Life in Postmenopausal Women (NCT05850338) | Aylin Güneş | 2018-06-22 |
| HIRREM Hot Flashes Study (NCT03512002) | Wake Forest University Health Sciences | 2018-06-01 |
| Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer (NCT03122301) | Northwestern University | 2017-06-01 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms (NCT02803268) | Tanabe Pharma Corporation | 2016-06-01 |
| Study to Evaluate the Safety and Efficacy of RAD1901 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms (NCT02653417) | Radius Pharmaceuticals, Inc. | 2015-12-01 |
| Vasomotor Symptoms and Cardiovascular Control (NCT02202707) | Beth Israel Deaconess Medical Center | 2014-05-01 |
| Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients (NCT01353963) | Pfizer | 2012-03-01 |
| A Study of MF101 in Postmenopausal Women (NCT00906308) | Bionovo | 2011-10-01 |
| Dehydroepiandrosterone (DHEA) + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women (NCT01452373) | EndoCeutics Inc. | 2011-10-01 |
| Acupuncture in Menopause (NCT01276028) | Wake Forest University Health Sciences | 2011-04-01 |
| Duloxetine for Menopausal Depression (NCT01117857) | Massachusetts General Hospital | 2009-08-01 |
| MsFLASH-01: Escitalopram for Menopausal Symptoms in Midlife Women (NCT00894543) | Fred Hutchinson Cancer Center | 2009-07-01 |
| Study Evaluating the Potential of DVS SR to Inhibit the CYP2D6 Pathway (NCT00456898) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-01-01 |
| The Effect Of Dose Titration And Dose Tapering On The Tolerability Of DVS SR In Women With Vasomotor Symptoms (NCT00401245) | Pfizer | 2006-12-01 |
| Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women (NCT00397176) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-11-01 |
| Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms. (NCT00356447) | Bayer | 2006-05-01 |
| Study Comparing 17B Estradiol/TMG CC 1mg Vs. Tibolone In Postmenopausal Women (NCT00472004) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-02-01 |
| Mindfulness-Based Stress Reduction for Hot Flashes (NCT01052454) | University of Massachusetts, Worcester | 2005-09-01 |
| Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012) (NCT00560833) | Merck Sharp & Dohme LLC | 2004-10-15 |
| Treatment of Vasomotor Symptoms in Korean Post Menopausal Women (NCT00651599) | Bayer | 2004-07-01 |
| Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With Menopause (NCT00421031) | Wyeth is now a wholly owned subsidiary of Pfizer | 2003-12-01 |
| Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen (NCT00332553) | Eli Lilly and Company | 2002-02-01 |